Anil K. Malhotra mainly investigates Psychiatry, Schizophrenia, Psychosis, Internal medicine and Genetics. Anil K. Malhotra focuses mostly in the field of Psychiatry, narrowing it down to topics relating to MEDLINE and, in certain cases, Body mass index, Affect and Functional disability. His studies examine the connections between Schizophrenia and genetics, as well as such issues in Bipolar disorder, with regards to Genome-wide association study and Case-control study.
His research integrates issues of Dose–response relationship, Cognition, Neuroscience, Clinical psychology and Genetic determinism in his study of Psychosis. He has included themes like Developmental psychology, Neurocognitive, Verbal learning and Neuropsychology in his Clinical psychology study. His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Oncology and Antipsychotic.
Anil K. Malhotra mainly focuses on Psychiatry, Schizophrenia, Psychosis, Internal medicine and Genetics. His works in Bipolar disorder, Bipolar I disorder, Schizoaffective disorder, Schizophrenia and First episode are all subjects of inquiry into Psychiatry. His Schizophrenia research includes themes of Neurocognitive, Cognition, Disease and Clinical psychology.
He combines subjects such as Social cognition and Endophenotype with his study of Neurocognitive. Anil K. Malhotra regularly ties together related areas like Neuroscience in his Psychosis studies. His Internal medicine study incorporates themes from Risperidone, Endocrinology, Oncology and Genotype.
Anil K. Malhotra spends much of his time researching Neuroscience, Clinical psychology, Psychosis, Social cognition and Internal medicine. His Neuroscience study combines topics from a wide range of disciplines, such as Schizophrenia and Early psychosis. He has researched Psychosis in several fields, including Inferior longitudinal fasciculus, Verbal learning, Superior longitudinal fasciculus and Antipsychotic.
As a member of one scientific family, he mostly works in the field of Antipsychotic, focusing on Genome-wide association study and, on occasion, Psychiatry, Meta-analysis, Computational biology and Pharmacogenetics. In general Psychiatry, his work in Schizophrenia, Recent onset schizophrenia and Untreated psychosis is often linked to In patient linking many areas of study. His biological study spans a wide range of topics, including Endocrinology, Oncology and Cardiology.
His main research concerns Schizophrenia, Cognition, Genome-wide association study, Psychiatry and Social cognitive theory. His studies deal with areas such as Major depressive disorder, Pleiotropy, Allele and Genotype as well as Schizophrenia. His studies in Cognition integrate themes in fields like Evolutionary biology, Genetics, Randomized controlled trial, Meta-analysis and Computational biology.
His Genome-wide association study research includes elements of Polygenic risk score, Pharmacogenomics, Multifactorial Inheritance, Predictive value of tests and Antipsychotic. His Genetic architecture research extends to Psychiatry, which is thematically connected. His Social cognition study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Christoph U. Correll;Peter Manu;Vladimir Olshanskiy;Barbara Napolitano.
JAMA (2009)
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
A Functional Polymorphism in the COMT Gene and Performance on a Test of Prefrontal Cognition
Anil K. Malhotra;Lisa J. Kestler;Chiara Mazzanti;John A. Bates.
American Journal of Psychiatry (2002)
Genomewide association studies: history, rationale, and prospects for psychiatric disorders.
Sven Cichon;Nick Craddock;Mark Daly;Mark Daly;Stephen V. Faraone.
American Journal of Psychiatry (2009)
Disrupted in Schizophrenia 1 (DISC1): Association with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder
Colin A. Hodgkinson;David Goldman;Judith Jaeger;Shalini Persaud.
American Journal of Human Genetics (2004)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
Colm O'Dushlaine;Lizzy Rossin;Phil H. Lee;Laramie Duncan;Laramie Duncan.
Nature Neuroscience (2015)
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Terry E. Goldberg;Robert S. Goldman;Katherine E. Burdick;Anil K. Malhotra.
Archives of General Psychiatry (2007)
Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
P R Szeszko;P R Szeszko;R Lipsky;C Mentschel;D Robinson;D Robinson.
Molecular Psychiatry (2005)
Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia
Robert M. Bilder;Jan Volavka;Pál Czobor;Anil K. Malhotra.
Biological Psychiatry (2002)
Pharmacogenetics of Psychotropic Drug Response
Anil K. Malhotra;Greer M. Murphy;James L. Kennedy.
American Journal of Psychiatry (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brigham and Women's Hospital
Feinstein Institute for Medical Research
Feinstein Institute for Medical Research
Centre for Addiction and Mental Health
National Institutes of Health
Charité - University Medicine Berlin
National Institutes of Health
Trinity College Dublin
University of California, Los Angeles
University of California, Los Angeles
European Molecular Biology Laboratory
Kyoto University
Chinese Academy of Sciences
Sungkyunkwan University
University of Queensland
University of Liverpool
Grenoble Alpes University
University of Michigan–Ann Arbor
Harvard University
Oregon State University
University of Helsinki
California Institute of Technology
Stanford University
University of California, San Francisco
University of California, San Francisco
Brigham and Women's Hospital